Lassman Law+Policy is a boutique law firm located in Washington, D.C. that focuses on solving its clients’ most complicated FDA-related problems. The firm works with sophisticated pharmaceutical, biotechnology, and medical device companies as well as investors and industry trade associations. Whether it is a cutting-edge exclusivity issue, a stalled approval program, or a biosimilar policy initiative, Lassman Law+Policy has the expertise and experience to resolve it. Scott Lassman is a recognized expert with nearly thirty years of experience in FDA law. In 2018, he was named one of the top five FDA regulatory attorneys in the United States.
Scott’s experience helps clients navigate the many legal gray areas they face, avoiding unseen dangers and taking advantage of hidden opportunities. Scott doesn’t just know the law, he knows the FDA — how it operates and how it interprets and enforces the law. Scott also is attuned to the special needs of corporate clients because he’s been one himself. In addition to his many years in private practice, Scott has worked in-house at both a mid-size drug company and a national trade association representing the innovative pharmaceutical industry. Because of this valuable experience, Scott seeks to provide practical solutions to his clients that focus, first and foremost, on achieving their business objectives. And he seeks to do so efficiently and on time.